Soluble urokinase plasminogen activator receptor (suPAR) can predict long-term mortality in patients with acute chest pain

被引：0
|
作者：
Chew-Harris, J. [1 ]
Appleby, S. [1 ]
Troughton, R. W. [1 ]
Richards, A. M. [1 ]
Pemberton, C. J. [1 ]
机构：
[1] Univ Otago Christchurch, Med, Christchurch, New Zealand
来源：
EUROPEAN HEART JOURNAL | 2020年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1695 / 1695
页数：1
相关论文
共 50 条
  • [31] Circulating levels of soluble urokinase plasminogen activator receptor (suPAR) predict outcome after resection of cholangiocarcinoma
    Loosen, Sven
    Tacke, Frank
    Breuer, Annemarie
    Kather, Jakob
    Longerich, Thomas
    Koch, Alexander
    Trautwein, Christian
    Roderburg, Christoph
    Neumann, Ulf
    Luedde, Tom
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E840 - E841
  • [32] The Role of Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Early Indicator of Mortality in Pediatric Septic Shock
    Turan, Caner
    Yurtseven, Ali
    Ozkaya, Pinar Yazici
    Azarsiz, Elif
    Saz, Eylem Ulas
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2024, 38 (09)
  • [33] Soluble urokinase plasminogen activator receptor (suPAR) levels in healthy pregnancy and preeclampsia
    Toldi, Gergely
    Biro, Edina
    Szalay, Balazs
    Stenczer, Balazs
    Molvarec, Attila
    Rigo, Janos, Jr.
    Vasarhelyi, Barna
    Beko, Gabriella
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (11) : 1873 - 1876
  • [34] Plasma Soluble Urokinase Plasminogen Activator Receptor (suPAR) and CKD Progression in Children
    Weidemann, Darcy K.
    Abraham, Alison G.
    Roem, Jennifer L.
    Furth, Susan L.
    Warady, Bradley A.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 76 (02) : 194 - 202
  • [35] The cardioprotective potential of soluble urokinase Plasminogen Activator Receptor (suPAR) in myocardial ischemia
    Pirker, T.
    Keys, T.
    Pham, T.
    Montecillo, J.
    Byers, M.
    Adamson, P.
    Richards, A. M.
    Pemberton, C.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [36] Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in ankylosing spondylitis
    Toldi, Gergely
    Szalay, Balazs
    Beko, Gabriella
    Kovacs, Laszlo
    Vasarhelyi, Barna
    Balog, Attila
    JOINT BONE SPINE, 2013, 80 (01) : 96 - 98
  • [37] Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation
    Rasmussen, Line Jee Hartmann
    Petersen, Jens Emil Vang
    Eugen-Olsen, Jesper
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [38] Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonism
    Joyce, Jessica
    Cabanas, Noel
    Pisharody, Rohan
    Ouyang, Bichun
    Patel, Roshni
    Reiser, Jochen
    Hall, Deborah A.
    Witek, Natalie
    PARKINSONISM & RELATED DISORDERS, 2022, 101 : 39 - 42
  • [39] Soluble urokinase Plasminogen Activator Receptor (suPAR) serum levels are elevated in patients with neuroendocrine neoplasia
    Burcin, Oe
    Mohr, R.
    Jann, H.
    Geisler, L.
    Tacke, F.
    Wiedenmann, B.
    Roderburg, C.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 96 - 96
  • [40] Soluble urokinase-type plasminogen activator receptor (SuPAR) in patients with Parkinson's disease
    Witek, N.
    Joyce, J.
    Hawkins, J.
    Liu, Y.
    Ouyang, B.
    Patel, R.
    Borgia, J.
    Reiser, J.
    Hall, D.
    MOVEMENT DISORDERS, 2021, 36 : S460 - S460
12345